User:Mr. Ibrahem/Sofosbuvir/velpatasvir/voxilaprevir

Sofosbuvir/velpatasvir/voxilaprevir, sold under the brand name Vosevi, is a combination medication used to treat hepatitis C. It is taken by mouth with food. Effectiveness is greater than 95%.

Common side effects include headache, tiredness, diarrhea, trouble sleeping, and nausea. Other side effects may include hepatitis B reactivation and liver problems. While there is no clear evidence of harm during pregnancy, it has not been well studied in this group. It contains sofosbuvir, velpatasvir, and voxilaprevir, each of which blocks an enzyme required by the virus.

The combination was approved for medical use in the United States and Europe in 2017. In the United States 8 weeks of treatment costs about 48,500 USD as of 2021. This amount in the United Kingdom costs the NHS about £30,000.